Anika Therapeutics Statistics
NASDAQ: ANIKHealth CareMedical/Dental InstrumentsUSD
13.23-0.05 (-0.38%)
At close: Nov 20, 4:00 PM ET · Delayed 15 min
Anika Therapeutics by the numbers
Anika Therapeutics has a market capitalization of $177.2 million based on 13.40M shares outstanding. With trailing EPS of $-0.03, Anika Therapeutics is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 29.9% below its 50-day average and 19.8% below its 200-day average.
Average daily trading volume is 105.68K shares, or about $1.4 million in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
ANIK valuation vs. peer median
| Metric | ANIK | Peer median | Difference |
|---|---|---|---|
| Market cap | $177.22M | $199.81M | -11% |
| Avg. volume | 105.68K | 178.14K | -41% |
Peer median across 8 companies: UTMD, PDEX, KTWO, KRMD, CLPT, PYPD, PROF, STIM.
Valuation
- Market cap
- $177.22M
- Forward P/E
- 13.23
- Price / sales (latest FY)
- 1.57
- EPS (TTM)
- $-0.03
- Shares outstanding
- 13.40M
Price and trading
- Previous close
- 13.28
- Open
- 13.30
- Day range
- 12.98 – 13.70
- 52-week range
- 9.01 – 22.88
- 52-week change
- +33.91%
- Beta
- —
- Volume
- 166.48K
- Average volume
- 105.68K
Dividends and events
- Annual dividend
- None
- Next earnings date
- Nov 6, 2026
Additional statistics
- Market Cap
- 177.22M
- Forward Pe
- 13.23
- Eps
- -0.03
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 22.88
- Week52 Low
- 9.01
- Avg Volume
- 105.68K
- Shares Outstanding
- 13.40M
- Ma50
- 18.88
- Ma200
- 16.50
- Earnings Date
- Nov 6, 2026
- Pct From52w High
- -42.18%
- Pct From52w Low
- 46.84%